Patents by Inventor Rupinder Kular

Rupinder Kular has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 11279982
    Abstract: Provided herein is technology relating to detecting molecular markers relevant to cancer and particularly, but not exclusively, to methods and compositions for quantifying and/or detecting EGFR mRNA and/or EGFRvIII mRNA in biological samples.
    Type: Grant
    Filed: January 2, 2020
    Date of Patent: March 22, 2022
    Assignee: ABBOTT MOLECULAR INC.
    Inventors: Jeffrey D. Wuitschick, Kevin S. Nelson, Shihai Huang, Rupinder Kular, Carolyn Mullen, James Rhoads
  • Publication number: 20200172983
    Abstract: Provided herein is technology relating to detecting molecular markers relevant to cancer and particularly, but not exclusively, to methods and compositions for quantifying and/or detecting EGFR mRNA and/or EGFRvIII mRNA in biological samples.
    Type: Application
    Filed: January 2, 2020
    Publication date: June 4, 2020
    Inventors: Jeffrey D. Wuitschick, Kevin S. Nelson, Shihai Huang, Rupinder Kular, Carolyn Mullen, James Rhoads
  • Patent number: 10538815
    Abstract: Provided herein is technology relating to detecting molecular markers relevant to cancer and particularly, but not exclusively, to methods and compositions for quantifying and/or detecting EGFR mRNA and/or EGFRvIII mRNA in biological samples.
    Type: Grant
    Filed: June 23, 2016
    Date of Patent: January 21, 2020
    Assignee: ABBOTT MOLECULAR INC.
    Inventors: Jeffrey D. Wuitschick, Kevin S. Nelson, Shihai Huang, Rupinder Kular, Carolyn Mullen, James Rhoads
  • Publication number: 20160376665
    Abstract: Provided herein is technology relating to detecting molecular markers relevant to cancer and particularly, but not exclusively, to methods and compositions for quantifying and/or detecting EGFR mRNA and/or EGFRvIII mRNA in biological samples.
    Type: Application
    Filed: June 23, 2016
    Publication date: December 29, 2016
    Inventors: Jeffrey D. Wuitschick, Kevin S. Nelson, Shihai Huang, Rupinder Kular, Carolyn Mullen, James Rhoads